{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:08:45Z","timestamp":1790518125306,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1009461","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000}}],"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011272","name":"FP7 Health","doi-asserted-by":"crossref","award":["GA 279185"],"award-info":[{"award-number":["GA 279185"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p><jats:italic>Neisseria meningitidis<\/jats:italic>is a strictly human pathogen and is the major cause of septicemia and meningitis worldwide. Factor H binding protein (fHbp) is a meningococcal surface-exposed lipoprotein that binds the human Complement factor H allowing the bacterium to evade the host innate immune response. FHbp is also a key antigen in two vaccines against<jats:italic>N<\/jats:italic>.<jats:italic>meningitidis<\/jats:italic>serogroup B. Although the<jats:italic>fHbp<\/jats:italic>gene is present in most circulating meningococcal strains, level of fHbp expression varies among isolates and has been correlated to differences in promoter sequences upstream of the gene. Here we elucidated the sequence determinants that control fHbp expression in globally circulating strains. We analyzed the upstream<jats:underline><jats:italic>f<\/jats:italic><\/jats:underline><jats:italic>Hbp<\/jats:italic><jats:underline>i<\/jats:underline>ntergenic<jats:underline>r<\/jats:underline>egion (fIR) of more than 5800 strains representative of the UK circulating isolates and we identified eleven fIR sequence alleles which represent 88% of meningococcal strains. By engineering isogenic recombinant strains where fHbp expression was under the control of each of the eleven fIR alleles, we confirmed that the fIR sequence determines a specific and distinct level of expression. Moreover, we identified the molecular basis for variation in expression through polymorphisms within key regulatory regions that are known to affect fHbp expression. We experimentally established three expression groups, high\u2013medium\u2013low, that correlated directly with the susceptibility to killing mediated by anti-fHbp antibodies and the ability of the meningococcal strain to survive within human serum. By using this sequence classification and information about the variant, we predicted fHbp expression in the panel of UK strains and we observed that strains with higher expressing fIR alleles are more likely associated with invasive disease. Overall, our findings can contribute to understand and predict vaccine coverage mediated by fHbp as well as to shed light on the role of this virulence factor in determining an invasive phenotype.<\/jats:p>","DOI":"10.1371\/journal.ppat.1009461","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T17:43:33Z","timestamp":1616780613000},"page":"e1009461","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Deconvolution of intergenic polymorphisms determining high expression of Factor H binding protein in meningococcus and their association with invasive disease"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5098-3901","authenticated-orcid":true,"given":"Marco","family":"Spinsanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4601-4080","authenticated-orcid":true,"given":"Tarcisio","family":"Brignoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7054-8712","authenticated-orcid":true,"given":"Margherita","family":"Bodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-1084","authenticated-orcid":true,"given":"Lucia Eleonora","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1014-350X","authenticated-orcid":true,"given":"Matteo","family":"De Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Biolchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8635-6424","authenticated-orcid":true,"given":"Alessandro","family":"Muzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-677X","authenticated-orcid":true,"given":"Vincenzo","family":"Scarlato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Delany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"ppat.1009461.ref001","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fped.2018.00321","article-title":"Invasive Meningococcal Disease in the Vaccine Era.","volume":"6","author":"S Nadel","year":"2018","journal-title":"Front Pediatr"},{"issue":"Suppl 2","key":"ppat.1009461.ref002","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"27","author":"LH Harrison","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"ppat.1009461.ref003","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"MC Maiden","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"ppat.1009461.ref004","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1084\/jem.20050112","article-title":"A chromosomally integrated bacteriophage in invasive meningococci","volume":"201","author":"E Bille","year":"2005","journal-title":"The Journal of experimental medicine"},{"issue":"9","key":"ppat.1009461.ref005","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.0800151105","article-title":"Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis","volume":"105","author":"C Schoen","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"20","key":"ppat.1009461.ref006","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1128\/JB.00883-10","article-title":"Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence","volume":"192","author":"B Joseph","year":"2010","journal-title":"Journal of bacteriology"},{"issue":"1","key":"ppat.1009461.ref007","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12864-017-3789-0","article-title":"Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad.","volume":"18","author":"K Diallo","year":"2017","journal-title":"BMC Genomics"},{"issue":"Suppl 2","key":"ppat.1009461.ref008","doi-asserted-by":"crossref","first-page":"B90","DOI":"10.1016\/j.vaccine.2009.05.002","article-title":"Genetic polymorphisms in host response to meningococcal infection: the role of susceptibility and severity genes","volume":"27","author":"V Wright","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"ppat.1009461.ref009","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1586\/14787210.2014.966079","article-title":"Prognostic markers of meningococcal disease in children: recent advances and future challenges.","volume":"12","author":"M Montero-Martin","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"9","key":"ppat.1009461.ref010","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/ng.640","article-title":"Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease","volume":"42","author":"S Davila","year":"2010","journal-title":"Nat Genet"},{"key":"ppat.1009461.ref011","doi-asserted-by":"crossref","first-page":"35842","DOI":"10.1038\/srep35842","article-title":"Natural resistance to Meningococcal Disease related to CFH loci: Meta-analysis of genome-wide association studies.","volume":"6","author":"F Martinon-Torres","year":"2016","journal-title":"Sci Rep."},{"key":"ppat.1009461.ref012","first-page":"3","article-title":"Competition between antagonistic complement factors for a single protein on N","author":"JJ Caesar","year":"2014","journal-title":"meningitidis rules disease susceptibility. Elife"},{"issue":"10","key":"ppat.1009461.ref013","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/INF.0000000000000823","article-title":"Confirmation of Host Genetic Determinants in the CFH Region and Susceptibility to Meningococcal Disease in a Central European Study Sample.","volume":"34","author":"A Biebl","year":"2015","journal-title":"The Pediatric infectious disease journal"},{"issue":"1","key":"ppat.1009461.ref014","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4161\/viru.26515","article-title":"Meningococcal disease and the complement system","volume":"5","author":"LA Lewis","year":"2014","journal-title":"Virulence"},{"issue":"16","key":"ppat.1009461.ref015","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM198304213081601","article-title":"Prevalence of congenital or acquired complement deficiency in patients with sporadic meningococcal disease","volume":"308","author":"RT Ellison","year":"1983","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ppat.1009461.ref016","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02918259","article-title":"Complement deficiency states and meningococcal disease","volume":"12","author":"J Figueroa","year":"1993","journal-title":"Immunol Res"},{"issue":"10","key":"ppat.1009461.ref017","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.4049\/jimmunol.1103748","article-title":"The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci","volume":"188","author":"LA Lewis","year":"2012","journal-title":"Journal of immunology"},{"issue":"1","key":"ppat.1009461.ref018","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"G Madico","year":"2006","journal-title":"Journal of immunology"},{"issue":"12","key":"ppat.1009461.ref019","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","article-title":"Functional significance of factor H binding to Neisseria meningitidis","volume":"176","author":"MC Schneider","year":"2006","journal-title":"Journal of immunology"},{"issue":"6","key":"ppat.1009461.ref020","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/14760584.2015.1016915","article-title":"Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen.","volume":"14","author":"KL Seib","year":"2015","journal-title":"Expert review of vaccines"},{"issue":"2","key":"ppat.1009461.ref021","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera.","volume":"77","author":"DM Granoff","year":"2009","journal-title":"Infection and immunity"},{"issue":"29","key":"ppat.1009461.ref022","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"MM Giuliani","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"37","key":"ppat.1009461.ref023","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"HQ Jiang","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"ppat.1009461.ref024","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"V Masignani","year":"2003","journal-title":"The Journal of experimental medicine"},{"issue":"4","key":"ppat.1009461.ref025","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"LD Fletcher","year":"2004","journal-title":"Infection and immunity"},{"key":"ppat.1009461.ref026","article-title":"Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined","author":"M Biagini","year":"2016","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"ppat.1009461.ref027","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/IAI.00849-10","article-title":"Effect of factor H-binding protein sequence variation on factor H binding and survival of Neisseria meningitidis in human blood","volume":"79","author":"KY Dunphy","year":"2011","journal-title":"Infection and immunity"},{"issue":"1","key":"ppat.1009461.ref028","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/IAI.01071-08","article-title":"Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37","volume":"77","author":"KL Seib","year":"2009","journal-title":"Infection and immunity"},{"issue":"3","key":"ppat.1009461.ref029","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/600141","article-title":"Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis","volume":"200","author":"E Murphy","year":"2009","journal-title":"The Journal of infectious diseases"},{"issue":"3","key":"ppat.1009461.ref030","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/JB.01308-09","article-title":"Expression of factor H binding protein of meningococcus responds to oxygen limitation through a dedicated FNR-regulated promoter","volume":"192","author":"F Oriente","year":"2010","journal-title":"Journal of bacteriology"},{"issue":"9","key":"ppat.1009461.ref031","doi-asserted-by":"crossref","first-page":"e107240","DOI":"10.1371\/journal.pone.0107240","article-title":"Genetic diversity and levels of expression of factor H binding protein among carriage isolates of Neisseria meningitidis.","volume":"9","author":"L Lemee","year":"2014","journal-title":"PloS one"},{"issue":"35","key":"ppat.1009461.ref032","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1016\/j.vaccine.2011.06.025","article-title":"Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates","volume":"29","author":"JW Marsh","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"ppat.1009461.ref033","doi-asserted-by":"crossref","first-page":"e0197186","DOI":"10.1371\/journal.pone.0197186","article-title":"Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines.","volume":"13","author":"C Cayrou","year":"2018","journal-title":"PloS one"},{"issue":"9\u201310","key":"ppat.1009461.ref034","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1042\/CS20090513","article-title":"Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease","volume":"118","author":"DJ Hill","year":"2010","journal-title":"Clin Sci"},{"issue":"Pt 4","key":"ppat.1009461.ref035","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1099\/mic.0.054957-0","article-title":"The effect of iron availability on transcription of the Neisseria meningitidis fHbp gene varies among clonal complexes","volume":"158","author":"H Sanders","year":"2012","journal-title":"Microbiology"},{"issue":"7470","key":"ppat.1009461.ref036","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature12616","article-title":"Temperature triggers immune evasion by Neisseria meningitidis","volume":"502","author":"E Loh","year":"2013","journal-title":"Nature"},{"issue":"8","key":"ppat.1009461.ref037","doi-asserted-by":"crossref","first-page":"e1005794","DOI":"10.1371\/journal.ppat.1005794","article-title":"Thermoregulation of Meningococcal fHbp, an Important Virulence Factor and Vaccine Antigen, Is Mediated by Anti-ribosomal Binding Site Sequences in the Open Reading Frame.","volume":"12","author":"E Loh","year":"2016","journal-title":"PLoS pathogens."},{"issue":"5","key":"ppat.1009461.ref038","doi-asserted-by":"crossref","first-page":"e1002027","DOI":"10.1371\/journal.ppat.1002027","article-title":"Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival","volume":"7","author":"H Echenique-Rivera","year":"2011","journal-title":"PLoS pathogens"},{"issue":"11\u201312","key":"ppat.1009461.ref039","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0300-9084(97)86727-2","article-title":"Differential contributions of two elements of rho-independent terminator to transcription termination and mRNA stabilization","volume":"78","author":"H Abe","year":"1996","journal-title":"Biochimie"},{"key":"ppat.1009461.ref040","first-page":"61","volume-title":"Automatic Annotation of Microbial Genomes and Metagenomic Sequences.","author":"V Solovyev","year":"2011"},{"issue":"9","key":"ppat.1009461.ref041","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1073\/pnas.1222845110","article-title":"Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen","volume":"110","author":"E Malito","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"ppat.1009461.ref042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002981","article-title":"Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen Molecules.","volume":"8","author":"S Johnson","year":"2012","journal-title":"PLoS pathogens."},{"key":"ppat.1009461.ref043","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"BIGSdb: Scalable analysis of bacterial genome variation at the population level.","volume":"11","author":"KA Jolley","year":"2010","journal-title":"BMC bioinformatics"},{"issue":"7","key":"ppat.1009461.ref044","doi-asserted-by":"crossref","first-page":"e1001027","DOI":"10.1371\/journal.ppat.1001027","article-title":"The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement.","volume":"6","author":"LA Lewis","year":"2010","journal-title":"PLoS pathogens."},{"issue":"5","key":"ppat.1009461.ref045","doi-asserted-by":"crossref","first-page":"e00339","DOI":"10.1128\/mBio.00339-13","article-title":"Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis.","volume":"4","author":"LA Lewis","year":"2013","journal-title":"mBio"},{"issue":"21","key":"ppat.1009461.ref046","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2009.02.098","article-title":"Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus","volume":"27","author":"S Bambini","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"ppat.1009461.ref047","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1128\/CVI.00055-11","article-title":"Characterization of Neisseria meningitidis Isolates That Do Not Express the Virulence Factor and Vaccine Antigen Factor H Binding Protein","volume":"18","author":"J Lucidarme","year":"2011","journal-title":"Clinical and Vaccine Immunology"},{"issue":"5","key":"ppat.1009461.ref048","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.molcel.2018.05.008","article-title":"Accessibility of the Shine-Dalgarno Sequence Dictates N-Terminal Codon Bias in E. coli","volume":"70","author":"S Bhattacharyya","year":"2018","journal-title":"Mol Cell"},{"issue":"6","key":"ppat.1009461.ref049","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1084\/jem.20072577","article-title":"A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies","volume":"205","author":"MJ Uria","year":"2008","journal-title":"Journal of Experimental Medicine"},{"key":"ppat.1009461.ref050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.csbj.2018.02.002","article-title":"Interplay Between Virulence and Variability Factors as a Potential Driver of Invasive Meningococcal Disease.","volume":"16","author":"E Siena","year":"2018","journal-title":"Computational and structural biotechnology journal"},{"issue":"10","key":"ppat.1009461.ref051","doi-asserted-by":"crossref","first-page":"e47973","DOI":"10.1371\/journal.pone.0047973","article-title":"Meningococcal factor H binding protein fHbpd184 polymorphism influences clinical course of meningococcal meningitis.","volume":"7","author":"JR Piet","year":"2012","journal-title":"PloS one"},{"issue":"3","key":"ppat.1009461.ref052","doi-asserted-by":"crossref","first-page":"e0120757","DOI":"10.1371\/journal.pone.0120757","article-title":"Susceptibility to invasive meningococcal disease: polymorphism of complement system genes and Neisseria meningitidis factor H binding protein","volume":"10","author":"DT Bradley","year":"2015","journal-title":"PloS one"},{"key":"ppat.1009461.ref053","article-title":"Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide.","author":"A Muzzi","year":"2019","journal-title":"Vaccine"},{"issue":"5","key":"ppat.1009461.ref054","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jinf.2013.06.007","article-title":"Added value of PCR-testing for confirmation of invasive meningococcal disease in England","volume":"67","author":"E Heinsbroek","year":"2013","journal-title":"The Journal of infection"},{"key":"ppat.1009461.ref055","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.85.6.1274-1279.1963","article-title":"Neisseria Gonorrhoeae. I. Virulence Genetically Linked to Clonal Variation","volume":"85","author":"DS Kellogg","year":"1963","journal-title":"Journal of bacteriology"},{"key":"ppat.1009461.ref056","volume-title":"Molecular cloning: a laboratory manual.","author":"FE Sambrook J","year":"1989","edition":"2"},{"key":"ppat.1009461.ref057","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-59745-196-3_6","article-title":"The Polymerase Incomplete Primer Extension (PIPE) method applied to high-throughput cloning and site-directed mutagenesis.","volume":"498","author":"HE Klock","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"2","key":"ppat.1009461.ref058","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/IAI.00891-10","article-title":"Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies.","volume":"79","author":"KL Seib","year":"2011","journal-title":"Infection and immunity"},{"issue":"10","key":"ppat.1009461.ref059","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1128\/JB.187.10.3421-3430.2005","article-title":"CrgA is an inducible LysR-type regulator of Neisseria meningitidis, acting both as a repressor and as an activator of gene transcription","volume":"187","author":"R Ieva","year":"2005","journal-title":"Journal of bacteriology"},{"issue":"4","key":"ppat.1009461.ref060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"issue":"2","key":"ppat.1009461.ref061","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/IAI.73.2.1151-1160.2005","article-title":"The region comprising amino acids 100 to 255 of Neisseria meningitidis, lipoprotein GNA 1870 elicits bactericidal antibodies","volume":"73","author":"MM Giuliani","year":"2005","journal-title":"Infection and Immunity"},{"issue":"12","key":"ppat.1009461.ref062","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","article-title":"Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data","volume":"28","author":"M Kearse","year":"2012","journal-title":"Bioinformatics"},{"issue":"1","key":"ppat.1009461.ref063","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-2836(66)80258-9","article-title":"An Improved Method of Testing for Evolutionary Homology","volume":"16","author":"WM Fitch","year":"1966","journal-title":"J Mol Biol"},{"key":"ppat.1009461.ref064","doi-asserted-by":"crossref","first-page":"W70","DOI":"10.1093\/nar\/gkn188","article-title":"The Vienna RNA websuite","volume":"36","author":"AR Gruber","year":"2008","journal-title":"Nucleic acids research"},{"issue":"15","key":"ppat.1009461.ref065","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/bioinformatics\/btp250","article-title":"VARNA: Interactive drawing and editing of the RNA secondary structure","volume":"25","author":"K Darty","year":"2009","journal-title":"Bioinformatics"},{"issue":"7","key":"ppat.1009461.ref066","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/infdis\/jir466","article-title":"Changes in Serogroup and Genotype Prevalence Among Carried Meningococci in the United Kingdom During Vaccine Implementation","volume":"204","author":"AB Ibarz-Pav\u00f3n","year":"2011","journal-title":"The Journal of infectious diseases"},{"issue":"9320","key":"ppat.1009461.ref067","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"MCJ Maiden","year":"2002","journal-title":"The Lancet"},{"issue":"5","key":"ppat.1009461.ref068","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity","volume":"197","author":"MCJ Maiden","year":"2008","journal-title":"The Journal of infectious diseases"},{"key":"ppat.1009461.ref069","article-title":"Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1\u20134 cross-sectional survey results.","author":"JM MacLennan","journal-title":"The Lancet Infectious Diseases."},{"issue":"3","key":"ppat.1009461.ref070","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v017.i03","article-title":"The strucplot framework: visualizing multi-way contingency tables with VCD.","volume":"17","author":"D Meyer","year":"2006","journal-title":"J Stat Softw."}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1009461","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1009461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T15:42:31Z","timestamp":1671723751000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1009461"}},"subtitle":[],"editor":[{"given":"William M.","family":"Shafer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1009461","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1009461","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]}}}